vimarsana.com
Home
Live Updates
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle (VAN) : comparemela.com
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")
/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the Prior...
Related Keywords
Ira Duarte ,
Prnewswire Heron Therapeutics Inc ,
Crosslink Life Sciences ,
Heron Therapeutics Inc ,
Drug Administration ,
Exchange Commission ,
Nasdaq ,
Prior Approval Supplement ,
Vial Access Needle ,
Bill Forbes ,
Executive Vice President ,
Chief Development Officer ,
New Drug Application ,
Safety Information ,
Prescribing Information ,
Boxed Warning ,
Heron Therapeutics ,
Private Securities Litigation Reform Act ,
Annual Report ,
Quarterly Reports ,
Media Contact ,
Vice President ,
Chief Financial ,
comparemela.com © 2020. All Rights Reserved.